SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001125345-22-000111
Filing Date
2022-12-16
Accepted
2022-12-16 16:28:08
Documents
12
Period of Report
2022-12-14
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K mgnx-20221214.htm   iXBRL 8-K 32562
  Complete submission text file 0001125345-22-000111.txt   167044

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20221214.xsd EX-101.SCH 1899
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20221214_lab.xml EX-101.LAB 23832
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20221214_pre.xml EX-101.PRE 12706
6 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20221214_htm.xml XML 10832
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 221468305
SIC: 2834 Pharmaceutical Preparations